prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, page 1 / 2. copy No. Examination: Histopathological examination. Cost of diagnostic procedure. Gender: F. Material: Total organ resection - right breast. Internal referral. Expected time of examination: up to 8 working days. Clinical diagnosis: Based on PCI, cellulae carcinomatosae - lesion covering the lower part of the breast. Macroscopic description: Right breast sized 27 x 23 x 3 cm removed without axillary tissues and with a skin flap of 27 x 14 cm. Skin injected with blue dye. Tumour sized 2 x 1.8 x 2.5 cm found on the boundary of lower quadrants, located 3.0 cm from the lower edge, 1.0 cm from the. base and 2.5 cm from the skin. The other tumour sized 3.2 x 1.9 x 4.5 cm found 2 cm away from the first one (margins: lower boundary 1.0 cm, base 1.0 cm, skin. 3 cm). Microscopic description: Carcinoma mucinosum invasivum bifocale - NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm). Foci of carcinoma ductale in situ (DCIS) found within the tumour (papillary, solid, mucous type, with. medium nuclear atypia, without necrosis, 20% of the tumour). Carcinoma intraductale mamillae. Glandular tissue showing parenchymal atrophy. Histopathological diagnosis: Including test No. ,. Carcinoma mucinosum invasivum et ductale in situ mammae dextrae. Invasive mucinous carcinoma and ductal carcinoma in situ. of the right breast. (NHG2, pT2, pNO (sn)). Compliance valid. Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in over 75% of neoplastic cell nuclei. HER2 protein stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Score = 2+ FISH verification recommended. Compliance validated bv: Examination: Histopathological examination. page 2 / 2. Gender: F. Result of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe. Kit FINAL RESULT: HER-2 GENE AMPLIFICATION NOT FOUND.

expanded version (tokens=961) : 
 Here is the extracted information from the breast pathology report:

- Histological classification: Invasive mucinous carcinoma and ductal carcinoma in situ of the right breast.
- Subtype: Luminal A (based on positive estrogen and progesterone receptor status, and negative HER2 receptor status).
- Description of any necrosis: DCIS foci present but without necrosis.
- Mention of tumor-infiltrating lymphocytes: None mentioned.
- Histological grade: NHG2 (3+2+1/5 mitoses/10 HPF - visual area 0.55mm).
- Nuclear grade: Not specified.
- Lymphovascular invasion: Not mentioned.
- Calcification: Not mentioned.
- Receptor status: Estrogen receptors found in over 75% of neoplastic cell nuclei; Progesterone receptors found in over 75% of neoplastic cell nuclei; HER2 protein stained using rabbit antibody Ventana PATHWAY HER-2/neu (4B5). Score = 2+ FISH verification recommended; HER-2 gene amplification not found after FISH testing.
- Ancillary testing results: FISH verification for HER2 protein was recommended, and final result was negative for HER-2 gene amplification.

Overall, the report describes a Luminal A subtype breast cancer with both invasive mucinous carcinoma and ductal carcinoma in situ present. The cancer is of NHG2 histological grade and showed positive estrogen and progesterone receptor

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1086) : 
 The breast pathology report indicates a Luminal A subtype of breast cancer, with invasive mucinous carcinoma and ductal carcinoma in situ in the right breast. The cancer is of NHG2 histological grade and positive for estrogen and progesterone receptors. The HER2 gene amplification result was negative after FISH testing. No mention of lymphovascular invasion or calcification was found.

